Perigon Wealth Management, LLC Sarepta Therapeutics, Inc. Transaction History

Perigon Wealth Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 13, 2022	SELL	$75.71 - $119.24 $37,855 - $59,620	-500 Reduced 16.37%	2,554 $282,000
Q2 2022 Aug 11, 2022	BUY	$62.69 - $88.44 $626 - $884	10 Added 0.33%	3,054 $229,000
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $189 - $271	-3 Reduced 0.1%	3,044 $238,000
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $309 - $397	4 Added 0.13%	3,047 $274,000
Q3 2021 Nov 01, 2021	BUY	$65.97 - $92.48 $200,746 - $281,416	3,043 New	3,043 $281,000
Q3 2021 Oct 25, 2021	SELL	$65.97 - $92.48 $193,160 - $270,781	-2,928 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$69.38 - $86.75 $693 - $867	10 Added 0.34%	2,928 $228,000
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $29,550 - $69,100	409 Added 16.3%	2,918 $217,000
Q4 2020 Jan 28, 2021	BUY	$125.56 - $178.74 $502 - $714	4 Added 0.16%	2,509 $428,000
Q3 2020 Nov 03, 2020	SELL	$127.12 - $172.34 $151,908 - $205,946	-1,195 Reduced 32.3%	2,505 $352,000
Q1 2020 Apr 17, 2020	BUY	$82.38 - $131.64 $304,806 - $487,067	3,700 New	3,700 $402,000
Q4 2018 Feb 11, 2019	SELL	$97.32 - $148.76 $535,551 - $818,626	-5,503 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $634,550 - $888,789	5,503 New	5,503 $889,000
Q3 2011 Nov 14, 2022	SELL	N/A	-500	2,554 $282,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.